REQUEST A DEMO
Total
USD $0.00
Search more companies

Lureen Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Lureen Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Lureen Sdn. Bhd. is an enterprise in Malaysia, with the main office in Petaling Jaya. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on August 31, 2007. From the latest financial highlights, Lureen Sdn. Bhd. reported a net sales revenue drop of 36.15% in 2023. Its’ total assets recorded a negative growth of 49.08%. In 2023, Lureen Sdn. Bhd.’s net profit margin decreased by 8.45%.

Headquarters
Af02, Perdana View Condominium, Damansara Perdana
Petaling Jaya; Selangor; Postal Code: 47820

Contact Details: Purchase the Lureen Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Lureen Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Lureen Sdn. Bhd. report to view the information.
Incorporation Date:
August 31, 2007
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
88.89%
Purchase this report to view the information.
11.11%
Company Performance
Financial values in the chart are available after Lureen Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-36.15%
Total operating revenue
-36.15%
Operating profit (EBIT)
12.3%
EBITDA
12.05%
Net Profit (Loss) for the Period
12.3%
Total assets
-49.08%
Total equity
-107.56%
Operating Profit Margin (ROS)
-8.45%
Net Profit Margin
-8.45%
Return on Equity (ROE)
-70.82%
Quick Ratio
-0.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?